
Global-Standard Quality. Trusted Compliance.
BioCina delivers biologics and injectable drug product programs with world-class quality systems and global regulatory readiness, from development through commercial supply.

Our Quality System
BioCina's quality management framework rests on decades of proven standards, refined through rigorous operations and inherited from a global pharmaceutical legacy. Every program is built on documentation that withstands scrutiny, operational consistency that survives audits, and a commitment to continuous improvement that keeps us ahead of regulatory change.
Our quality systems were forged under one of the world's most demanding pharmaceutical operating environments. That standard did not leave when the name changed.
No critical observations across regulatory inspections on record
Products approved and supplied across 140+ countries
Rigorous documentation and data integrity at every stage
Inspection-ready is not a target here, it is the baseline
Global Regulatory Reach
TGA GMP standards are harmonized with FDA and EMA through PIC/S membership, meaning BioCina-generated data supports approvals across the US, Europe, and key global markets. Batch release documentation is prepared in compliance with EU Annex 16, supporting European market access from our manufacturing operations.
Phase-Appropriate Quality Across Development, Tech Transfer, and Commercial Supply
Right-sized GMP at each stage, aligned with PDA TR 56 and ICH guidance, avoiding over-engineering early programs while ensuring full readiness for commercial manufacture and scale-up.


Confidence in Every Batch. Ready to Scale With Confidence.
Choose BioCina for a partner who delivers reliability, compliance, and operational excellence at global scale.








